Cyclerion Therapeutics

11 clinical trials · Sponsor

Record	Firm	Date
A Trial to Evaluate the Effect of Itraconazole (ITZ), a CYP3A4 Inhibitor, on the Pharmacokinetics of the Soluble Guanylate Cyclase Stimulator, Olinciguat (IW-1701), in Healthy Volunteers (NCT03892499)	Cyclerion Therapeutics	2019-05-03
A Trial to Study the Absorption, Metabolism, and Excretion of [14C]-Praliciguat in Healthy Male Volunteers (NCT03818295)	Cyclerion Therapeutics	2019-03-01
A Trial to Study the Absorption, Metabolism, and Excretion of [14C]-Olinciguat in Healthy Male Volunteers (NCT03795519)	Cyclerion Therapeutics	2019-01-17
A Trial to Evaluate the Effect of Itraconazole (ITZ), a CYP3A4 Inhibitor, on the Pharmacokinetics of Praliciguat (IW-1973) in Healthy Volunteers (NCT03499106)	Cyclerion Therapeutics	2018-04-12
A Study of the Effect of IW-1701 (Olinciguat), a Stimulator of Soluble Guanylate Cyclase (sGC), on Patients With Sickle Cell Disease (SCD) (NCT03285178)	Cyclerion Therapeutics	2017-12-22
Study of IW-1701, A Stimulator of Soluble Guanylate Cyclase (sGC), in Patients With Type I or II Achalasia (NCT02931565)	Cyclerion Therapeutics	2017-04-06
Trial of IW-1973, A Stimulator of Soluble Guanylate Cyclase (sGC) in Patients With Stable Type 2 Diabetes and Hypertension (NCT03091920)	Cyclerion Therapeutics	2017-02-28
A Phase 2 Trial of IW-1973, A Stimulator of Soluble Guanylate Cyclase (sGC), in Patients With Stable Type 2 Diabetes and Hypertension (NCT02906579)	Cyclerion Therapeutics	2016-09-01
A Trial of IW-1701, A Stimulator of Soluble Guanylate Cyclase (sGC), in Healthy Subjects (NCT02792998)	Cyclerion Therapeutics	2016-05-01
Trial of IW-1973 (A Stimulator of Soluble Guanylate Cyclase (sGC)) in Healthy Volunteers (NCT02616861)	Cyclerion Therapeutics	2015-11-01
Trial of IW-1701 (A Stimulator of Soluble Guanylate Cyclase (sGC)) in Healthy Volunteers (NCT02572349)	Cyclerion Therapeutics	2015-10-01

Track Cyclerion Therapeutics automatically

Every clearance here is in the API, with alerts when new ones post.